One of Pharmalicensing’s recent clients is Gary Clark of Immunology Laboratories, based in Alabama in the United States. Immunology Laboratories develops novel technological inventions for the treatment of staphylococcal infections in humans and animals.

Immunology Laboratories profiled with Pharmalicensing in mid-2005 after a positive recommendation from an associate at the patent attorney company Troutman and Sanders.

Mr Clark assessed the site and chose to profile, as he believed that Pharmalicensing was the most popular site of its kind. He found it easy to navigate around and felt it offered the highest probability of accomplishing a good partner. Immunology Laboratories is seeking a long-term partnership with a large mature pharmaceutical company in the infectious disease area.

Mr Clark explained how he monitors his profile. “We use the site mainly for our partnering needs; we look to see if any interest has been generated. We check our updates and see if there are any developments. We like the fact that the site allows companies to see what we do too.”

Visiting the site twice a week, Mr Clark believes that one of the most useful features is being listed alongside the many potential partnering companies. “People looking for partners will notice us,” he said.

Although Immunology Laboratories has only been with Pharmalicensing for a short time, it has already generated positive responses from a number of companies.

Mr Clark feels that profiling with Pharmalicensing is efficient, as it allows Immunology Laboratories to eliminate certain companies from its mission to find a partner.

Mr Clark is optimistic about his future with Pharmalicensing. “We hope that Pharmalicensing will bring us a partner who has the resources to help us bring our products to the marketplace.” Mr Clark concluded by saying that he would definitely recommend Pharmalicensing. “Anyone who has a partnering pharmaceutical company should certainly consider making use of the website and related services.”

View Immunology Laboratories' profile

See Immunology Laboratories' licensing opportunities.

To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article please subscribe to our PL Intelligence service.

The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing or UTEK Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.